MathewRWilliamsMD
Thoracic Surgery • New York, NYAdult Cardiac Surgery, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery
Chief, Adult Cardiac Surgery Director, Heart Valve Program Director, Interventional Cardiology
Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 1st Ave
New York, NY 10016Phone+1 212-263-7185Fax+1 212-263-2042
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2006 - 2006- New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery, 2004 - 2005
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2003
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1996 - 2000
Columbia University Vagelos College of Physicians and SurgeonsClass of 1996
Certifications & Licensure
NY State Medical License 1998 - 2025
CT State Medical License 2013 - 2016
FL State Medical License 2011 - 2015
NC State Medical License 2012 - 2015
NJ State Medical License 2012 - 2015
TN State Medical License 2012 - 2014- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Top Doctors: New York Metro Area Castle Connolly, 2011-2014
- New York Magazine: Top Doctors Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Hybrid Revascularization Observational Study Start of enrollment: 2010 May 01
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1788 citationsExpression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursorsMario Peichev, Afzal J. Naiyer, Daniel S. Pereira, Zhenping Zhu, William J. Lane
Blood. 2000-02-01 - 4549 citationsTranscatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsCraig R. Smith, Martin B. Leon, Michael J. Mack, D. Craig Miller, Jeffrey W. Moses
The New England Journal of Medicine. 2011-06-08 - 301 citationsPredictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis A Placement of Aortic Transcatheter Valves (PARTNER) Trial AnalysisHoward C. Herrmann, Philippe Pibarot, Irene Hueter, Zachary M. Gertz, William J. Stewart
Circulation. 2013-06-11
Journal Articles
- Outcomes After Transcatheter Aortic Valve Replacement in Patients with Low Versus High Gradient Severe Aortic Stenosis in the Setting of Preserved Left Ventricular Eje...Cezar Staniloae, Ricardo Benenstein, Umair Jangda, Muhamed Saric, Mathew R Williams, Daniel McDonald, Alan Vainrib, Robert Donnino, Journal of Interventional Cardiology
Lectures
- Optimum Transcatheter Aortic Valve: Global First-in-HumanCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Technology Description and Clinical DataCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- OPTIMUM TAV First-In-Human ResultsCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Press Mentions
No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry ShowsDecember 29th, 2022- Good Results for TAVI in Bicuspid Valves, but Questions PersistMarch 8th, 2022
- After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be UnlikelyJuly 21st, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
